Dalteparin for pregnant women with thrombophilia - authors' reply.

Saved in:
Bibliographic Details
Title: Dalteparin for pregnant women with thrombophilia - authors' reply.
Authors: Rodger MA; Thrombosis Program, Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, ON, Canada; Ottawa Hospital Research Institute, Ottawa, ON K1H8L6, Canada. Electronic address: mrodger@ohri.ca., Hague WM; Obstetric Medicine, Robinson Institute, University of Adelaide, Women's and Children's Hospital, Adelaide, SA, Australia., Kingdom J; Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada., Kahn SR; Centre for Clinical Epidemiology, Jewish General Hospital, Montreal, QC, Canada., Wells PS; Ottawa Hospital Research Institute, Ottawa, ON K1H8L6, Canada.
Source: Lancet (London, England) [Lancet] 2015 Feb 21; Vol. 385 (9969), pp. 690. Date of Electronic Publication: 2015 Feb 20.
Publication Type: Letter; Comment
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-547X
DOI:10.1016/S0140-6736(15)60287-2